Aphel Online
The Inflammatory Bowel Disease (IBD) treatment market has witnessed significant growth, with a valuation of USD 19.6 billion in 2023. This growth trajectory is expected to continue, with the market projected to expand at a CAGR of 5.71% from 2024 to 2032, reaching a value of USD 32.3 billion by 2032. The driving forces behind […]
Inflammatory Bowel Disease (IBD), including Crohn’s Disease and Ulcerative Colitis, is a chronic gastrointestinal condition that affects millions of people worldwide. The Inflammatory Bowel disease treatment market, valued at USD 19.6 billion in 2023, is projected to reach USD 32.3 billion by 2032, growing at a CAGR of 5.71%. This growth is driven by an […]